Patel Nikunj, Lie Xandra, Gwaltney Chad, Rokutanda Nana, Barzi Afsaneh, Melisi Davide, Macarulla Teresa, Ueno Makoto, Kim Seung Tae, Meyers Oren, Workman Christina, Bachini Melinda, Cohen Gordon
AstraZeneca, 1 Medimmune Way, Gaithersburg, MD, 20878, USA.
IQVIA, Amsterdam, The Netherlands.
Oncol Ther. 2021 Dec;9(2):557-573. doi: 10.1007/s40487-021-00159-z. Epub 2021 Jul 10.
Patients living with biliary tract cancer (BTC) experience a decline in health-related quality of life (HRQoL). This study aimed to obtain a comprehensive understanding of the patient experience of BTC-related signs/symptoms and the impacts of these on daily functioning and HRQoL.
Patients with BTC participated in qualitative semi-structured concept elicitation interviews. Signs/symptoms and impacts of BTC were initially explored by targeted literature searches and interviews with five clinicians. Patient interviews were transcribed and coded using qualitative research software. Concept saturation was assessed over five interview waves. A sign/symptom or impact was defined as "salient" if mentioned by ≥ 50% of patients, with a mean disturbance rating of ≥ 5 (0-10 scale). A conceptual model of the patient experience of BTC-related signs/symptoms and impacts was produced.
Twenty-three patients from the USA (78% women; median age: 54 years), diagnosed as having early (n = 3), locally advanced (n = 11) or metastatic (n = 9) disease, were interviewed. Sixty-six signs/symptoms and 12 impacts were identified. Of these, 46 signs/symptoms and 8 impacts were not identified from the targeted literature or clinician interviews. Concept saturation was reached by the fourth of five interview waves. Fourteen disease-related signs/symptoms (including fatigue/lack of energy, abdominal pain, lack of appetite, insomnia and diarrhoea) and three impacts (physical, emotional and cognitive impacts) were deemed "salient". The conceptual model included 50 signs/symptoms and 12 impacts.
Patients with BTC reported a range of signs/symptoms and impacts that negatively affect daily functioning and HRQoL.
胆管癌(BTC)患者的健康相关生活质量(HRQoL)会下降。本研究旨在全面了解患者对BTC相关体征/症状的体验以及这些体征/症状对日常功能和HRQoL的影响。
BTC患者参与了定性半结构化概念引出访谈。BTC的体征/症状及影响最初通过针对性文献检索和对五名临床医生的访谈进行探索。患者访谈内容被转录并使用定性研究软件进行编码。在五轮访谈中评估概念饱和度。如果≥50%的患者提及某一体征/症状或影响,且平均干扰评分为≥5(0-10分制),则将其定义为“显著的”。构建了一个关于BTC相关体征/症状及影响的患者体验概念模型。
对来自美国的23名患者(78%为女性;中位年龄:54岁)进行了访谈,这些患者被诊断为早期(n = 3)、局部晚期(n = 11)或转移性(n = 9)疾病。共识别出66种体征/症状和12种影响。其中,46种体征/症状和8种影响在针对性文献或临床医生访谈中未被识别。在五轮访谈的第四轮达到了概念饱和度。14种与疾病相关的体征/症状(包括疲劳/精力不足、腹痛、食欲不振、失眠和腹泻)和3种影响(身体、情感和认知影响)被认为是“显著的”。该概念模型包括50种体征/症状和12种影响。
BTC患者报告了一系列对日常功能和HRQoL产生负面影响的体征/症状及影响。